BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9731077)

  • 1. Evidence that CD31, CD49b, and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants.
    Maruya E; Saji H; Seki S; Fujii Y; Kato K; Kai S; Hiraoka A; Kawa K; Hoshi Y; Ito K; Yokoyama S; Juji T
    Blood; 1998 Sep; 92(6):2169-76. PubMed ID: 9731077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD31 mismatching affects marrow transplantation outcome.
    Grumet FC; Hiraki DD; Brown BWM ; Zehnder JL; Zacks ES; Draksharapu A; Parnes J; Negrin RS
    Biol Blood Marrow Transplant; 2001; 7(9):503-12. PubMed ID: 11669217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recipient cytokine genotypes for TNF-alpha and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GVHD in unrelated cord blood transplantation: a retrospective analysis.
    Kögler G; Middleton PG; Wilke M; Rocha V; Esendam B; Enczmann J; Wernet P; Gluckman E; Querol S; Lecchi L; Goulmy E; Dickinson AM
    Transplantation; 2002 Oct; 74(8):1167-75. PubMed ID: 12438965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of polymorphic adhesion molecules in the development of graft-versus-leukemia effect after HLA-matched allogeneic stem cell transplantation].
    Shiobara S; Sato H; Furukawa T; Tsukada J; Yasue S; Takeda H; Togawa A; Taira M; Sakai Y; Aizawa Y; Nakao S
    Rinsho Ketsueki; 2004 Jul; 45(7):518-23. PubMed ID: 15359910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incompatibility for CD31 and human platelet antigens and acute graft-versus-host disease after bone marrow transplantation.
    Balduini CL; Noris P; Giorgiani G; Martinetti M; Klersy C; Spedini P; Belletti S; MacCario R; Gusberti L; Locatelli F
    Br J Haematol; 1999 Sep; 106(3):723-9. PubMed ID: 10468865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
    Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
    N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of disparity of minor histocompatibility antigens HA-1, CD31, and CD49b in hematopoietic stem cell transplantation of patients with chronic myeloid leukemia with sibling and unrelated donors.
    Heinemann FM; Ferencik S; Ottinger HD; Beelen DW; Grosse-Wilde H
    Transplantation; 2004 Apr; 77(7):1103-6. PubMed ID: 15087780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatch of minor histocompatibility antigen contributes to a graft-versus-leukemia effect rather than to acute GVHD, resulting in long-term survival after HLA-identical stem cell transplantation in Japan.
    Katagiri T; Shiobara S; Nakao S; Wakano M; Muranaka E; Kuba N; Furukawa T; Tsukada J; Takeda H; Aizawa Y; Harada M
    Bone Marrow Transplant; 2006 Nov; 38(10):681-6. PubMed ID: 16980988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor.
    Balduini CL; Frassoni F; Noris P; Klersy C; Iannone AM; Bacigalupo A; Giorgiani G; Di Pumpo M; Locatelli F
    Br J Haematol; 2001 Sep; 114(4):951-3. PubMed ID: 11564091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of adhesion molecule CD31 is not a significant risk factor for graft-versus-host disease.
    Nichols WC; Antin JH; Lunetta KL; Terry VH; Hertel CE; Wheatley MA; Arnold ND; Siemieniak DR; Boehnke M; Ginsburg D
    Blood; 1996 Dec; 88(12):4429-34. PubMed ID: 8977234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease.
    Behar E; Chao NJ; Hiraki DD; Krishnaswamy S; Brown BW; Zehnder JL; Grumet FC
    N Engl J Med; 1996 Feb; 334(5):286-91. PubMed ID: 8532023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation.
    Tseng LH; Lin MT; Hansen JA; Gooley T; Pei J; Smith AG; Martin EG; Petersdorf EW; Martin PJ
    Blood; 1999 Oct; 94(8):2911-4. PubMed ID: 10515896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation.
    Rufer N; Wolpert E; Helg C; Tiercy JM; Gratwohl A; Chapuis B; Jeannet M; Goulmy E; Roosnek E
    Transplantation; 1998 Oct; 66(7):910-6. PubMed ID: 9798702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation.
    Marijt EA; Veenhof WF; Goulmy E; Kluck PM; Brand A; Willemze R; van Rood JJ; Falkenburg JH
    Hum Immunol; 1993 Aug; 37(4):221-8. PubMed ID: 8300407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
    Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model.
    Dickinson AM; Sviland L; Wang XN; Jackson G; Taylor PR; Dunn A; Proctor SJ
    Transplantation; 1998 Oct; 66(7):857-63. PubMed ID: 9798694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
    Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
    Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor helper T-cell frequencies as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
    Weston LE; Geczy AF; Farrell C
    Transplantation; 1997 Sep; 64(6):836-41. PubMed ID: 9326407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.
    van Rood JJ; Loberiza FR; Zhang MJ; Oudshoorn M; Claas F; Cairo MS; Champlin RE; Gale RP; Ringdén O; Hows JM; Horowitz MH
    Blood; 2002 Mar; 99(5):1572-7. PubMed ID: 11861270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.